Literature DB >> 18393872

Supraventricular tachycardia in fetus: how can we treat ?

Maurizio Mongiovì1, Salvatore Pipitone.   

Abstract

The normal fetal cardiac rhythm is characterized by a regular heart rate ranging between 100 and 160 -180 beats/min with a normal 1: 1 atrioventricular electromechanical relationship during each cardiac cycle. Fetal tachycardia occurring in approximately 0.5% of all pregnancies and it is an important cause of fetal morbidity and mortality. A fetal tachycardic heart is at risk for developing low cardiac output, hydrops and ultimately fetal death or significant neurological morbidity. Different conditions can play a role to determine the natural history of tachycardic fetus as gestational age, underlying pathophysiology of the arrhythmia, fetal heart rate, duration of the tachyarrhythmia, and presence or absence of cardiac dysfunction. Reliable diagnosis in utero of fetal arrhythmia is possible by ultrasound examination of the fetal heart. In fact pulsed wave Doppler guided by two-dimensional echocardiography provided important information on cardiac rhythm as it study the blood flow from different chambers. With the introduction of the latest myocardial deformation methodology, the fetal tachyarrhythmias can be diagnosed more accu notrately. Precise diagnosis of cardiac arrhythmias in the fetus is crucial for a managed therapeutic approach. The choice of management is correlated to many factors: gestational age, underlying pathophysiology of the arrhythmia, fetal heart rate, duration of the tachyarrhythmia, and presence or absence of cardiac dysfunction. A large review of fetal arrhythmias was been reported in our work.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18393872     DOI: 10.2174/138161208784007725

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  5 in total

1.  Importance of Fetal Arrhythmias to the Neonatologist and Pediatrician.

Authors:  Annette Wacker-Gussmann; Ronald T Wakai; Janette F Strasburger
Journal:  Neoreviews       Date:  2016-10

2.  Non-immune hydrops foetalis due to foetal tachyarrhythmia-management with transplacental amiodarone.

Authors:  Mukti Sharma; K Kapur; B K Goyal; S Narayan; Vinay Jetley
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Tachycardia-induced cardiomyopathy after functional closure of the foramen ovale in a fetus.

Authors:  Elisabeth Mlczoch; Ulrike Salzer-Muhar; Barbara Ulm; Manfred Marx
Journal:  Pediatr Cardiol       Date:  2011-02-25       Impact factor: 1.655

4.  Postnatal outcome in patients with fetal tachycardia.

Authors:  Shreya Moodley; Shubhayan Sanatani; James E Potts; George G S Sandor
Journal:  Pediatr Cardiol       Date:  2012-05-26       Impact factor: 1.655

5.  Fetal supraventricular tachycardia and maternal COVID-19 vaccination: is there any relationship?

Authors:  Wael Abdallah; Johnny B Rechdan; Razane Lakkis; Malek Nassar; Linda Daou; Nadine El Kassis; David Atallah
Journal:  Future Sci OA       Date:  2022-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.